Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -27.44 | N/A |
PEG Ratio (TTM) | 2.45 | N/A |
P/S Ratio (TTM) | 3.22 | N/A |
P/B Ratio (TTM) | 5.02 | N/A |
P/FCF Ratio (TTM) | 44.32 | N/A |
Price to 5YR AVG Earnings Ratio | -18.46 | N/A |
Price to 5YR AVG FCF Ratio | 192.24 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.33% | N/A |
ROE (TTM) | -17.81% | N/A |
Net Profit Margin (TTM) | -11.67% | N/A |
ROIC 5YR AVG | -14.77% | N/A |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -283.47% | -20.14% | 0.53% |
Revenue | 0.76% | 35.81% | 25.71% |
Net Income | -285.44% | -30.07% | -6.42% |
Cash Flow | 31.06% | 102.24% | 111.49% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.67 | N/A |
Quick Ratio (TTM) | 0.67 | N/A |
D/E Ratio (TTM) | 1.25 | N/A |
Interest Coverage (TTM) | -47.11 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 0.75 | N/A |
LTL to 5YR AVG FCF | 39.14 | N/A |
Shares Outstanding Growth 5YR AVG | 7.00% | N/A |